J.R. Cashman
Human BioMolecular Research Institute
1604 29th Avenue West
Seattle
Washington 98199
USA
Name/email consistency: medium
- Population distribution of human flavin-containing monooxygenase form 3: gene polymorphisms. Cashman, J.R., Zhang, J., Leushner, J., Braun, A. Drug Metab. Dispos. (2001)
- Population-specific polymorphisms of the human FMO3 gene: significance for detoxication. Cashman, J.R., Akerman, B.R., Forrest, S.M., Treacy, E.P. Drug Metab. Dispos. (2000)
- Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure. Cashman, J.R., Berkman, C.E., Underiner, G.E. J. Pharmacol. Exp. Ther. (2000)
- Human flavin-containing monooxygenase: substrate specificity and role in drug metabolism. Cashman, J.R. Curr. Drug Metab. (2000)
- N-oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): role in bioactivation and detoxication. Cashman, J.R., Xiong, Y.N., Xu, L., Janowsky, A. J. Pharmacol. Exp. Ther. (1999)
- In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles. Cashman, J.R., Xiong, Y., Lin, J., Verhagen, H., van Poppel, G., van Bladeren, P.J., Larsen-Su, S., Williams, D.E. Biochem. Pharmacol. (1999)
- Cocaine benzoyl thioester: synthesis, kinetics of base hydrolysis, and application to the assay of cocaine esterases. Cashman, J.R., Berkman, C.E., Underiner, G., Kolly, C.A., Hunter, A.D. Chem. Res. Toxicol. (1998)